What is CURE Epilepsy?
Founded in 1998 and based in Chicago, Illinois, CURE Epilepsy is a dedicated non-profit organization committed to eradicating epilepsy through the strategic promotion and funding of patient-focused research. The organization operates within the non-profit and medical research sectors, focusing on finding a cure for this complex neurological disorder. Its late-stage funding context suggests a mature operational phase, likely involving scaled research initiatives and broader advocacy efforts.
How much funding has CURE Epilepsy raised?
CURE Epilepsy has raised a total of $440K across 2 funding rounds:
Debt
$150K
Debt
$290K
Debt (2020): $150K with participation from PPP
Debt (2021): $290K led by PPP
What's next for CURE Epilepsy?
With the recent strategic investment and a significant total funding base of $440K, CURE Epilepsy is poised to amplify its research initiatives and accelerate its progress towards a cure for epilepsy. The substantial capital will likely be directed towards expanding research grants, fostering collaborations with leading scientific institutions, and enhancing patient support programs. This financial backing is a testament to the organization's impactful work and its potential to achieve its ambitious goals in the fight against epilepsy.
See full CURE Epilepsy company page